Achieving sustained virological response: what's the impact on further hepatitis C virus-related disease?

被引:13
作者
van der Meer, Adriaan J. [1 ]
机构
[1] Erasmus MC Univ Med Ctr Rotterdam, Dept Gastroenterol & Hepatol, NL-3015 CE Rotterdam, Netherlands
关键词
all-cause mortality; antiviral therapy; chronic HCV infection; hepatic fibrosis; hepatocellular carcinoma; sustained virological response; VENOUS-PRESSURE GRADIENT; LIVER-RELATED MORTALITY; CHRONIC HCV INFECTION; ALL-CAUSE MORTALITY; HEPATOCELLULAR-CARCINOMA; ANTIVIRAL THERAPY; LONG-TERM; FOLLOW-UP; HISTOLOGIC IMPROVEMENT; PORTAL-HYPERTENSION;
D O I
10.1586/17474124.2015.1001366
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Continuous hepatic inflammation as a result of chronic infection with the hepatitis C virus may lead to the development of fibrosis and eventually cirrhosis. At the stage of cirrhosis, patients are at elevated risk of liver failure and hepatocellular carcinoma, two complications that shorten their life expectancy. Survival may be further impaired by the extra-hepatic manifestations of chronic hepatitis C virus infection, such as diabetes mellitus and lymphoma. Sustained virological response (SVR) following antiviral therapy has been associated with regression of hepatic fibrosis as well as with a reduction in portal pressure, both important markers of liver disease severity. Long-term follow-up studies indicated that SVR was related not only to a reduced occurrence of solid clinical end points, including liver failure and hepatocellular carcinoma, but also cardiovascular events and malignant lymphomas. Together, these findings may explain the recently observed improved overall survival among patients who attained SVR, even in the case of advanced liver disease.
引用
收藏
页码:559 / 566
页数:8
相关论文
共 65 条
[11]  
Coverdale SA, 2003, AM J GASTROENTEROL, V98, P1384, DOI 10.1111/j.1572-0241.2003.07468.x
[12]   A morphometric and immunohistochemical study to assess the benefit of a sustained virological response in hepatitis C virus patients with cirrhosis [J].
D'Ambrosio, Roberta ;
Aghemo, Alessio ;
Rumi, Maria Grazia ;
Ronchi, Guido ;
Donato, Maria Francesca ;
Paradis, Valerie ;
Colombo, Massimo ;
Bedossa, Pierre .
HEPATOLOGY, 2012, 56 (02) :532-543
[13]   Hepatic vein pressure gradient reduction and prevention of variceal bleeding in cirrhosis: A systematic review [J].
D'Amico, Gennaro ;
Garcia-Pagan, Juan Carlos ;
Luca, Angelo ;
Bosch, Jaime .
GASTROENTEROLOGY, 2006, 131 (05) :1611-1624
[14]   Aging of Hepatitis C Virus (HCV)-Infected Persons in the United States: A Multiple Cohort Model of HCV Prevalence and Disease Progression [J].
Davis, Gary L. ;
Alter, Miriam J. ;
El-Serag, Hashem ;
Poynard, Thierry ;
Jennings, Linda W. .
GASTROENTEROLOGY, 2010, 138 (02) :513-U141
[15]   Cirrhosis reversal: a duel between dogma and myth [J].
Desmet, VJ ;
Roskams, T .
JOURNAL OF HEPATOLOGY, 2004, 40 (05) :860-867
[16]   Peg-interferon alone or combined with ribavirin in HCV cirrhosis with portal hypertension:: A randomized controlled trial [J].
Di Marco, Vito ;
Almasio, Piero Luigi ;
Ferraro, Donatella ;
Calvaruso, Vincenza ;
Alaimo, Giuseppe ;
Peralta, Sergio ;
Di Stefano, Rosa ;
Craxi, Antonio .
JOURNAL OF HEPATOLOGY, 2007, 47 (04) :484-491
[17]   All-Cause, Liver-Related, and Non-Liver-Related Mortality Among HCV-Infected Individuals in the General US Population [J].
El-Kamary, Samer S. ;
Jhaveri, Ravi ;
Shardell, Michelle D. .
CLINICAL INFECTIOUS DISEASES, 2011, 53 (02) :150-157
[18]   Morbidity and mortality in compensated cirrhosis type C: A retrospective follow-up study of 384 patients [J].
Fattovich, G ;
Giustina, G ;
Degos, F ;
Tremolada, F ;
Diodati, G ;
Almasio, P ;
Nevens, F ;
Solinas, A ;
Mura, D ;
Brouwer, JT ;
Thomas, H ;
Njapoum, C ;
Casarin, C ;
Bonetti, P ;
Fuschi, P ;
Basho, J ;
Tocco, A ;
Bhalla, A ;
Galassini, R ;
Noventa, F ;
Schalm, SW ;
Realdi, G .
GASTROENTEROLOGY, 1997, 112 (02) :463-472
[19]   Treatment of HCV with ABT-450/r-Ombitasvir and Dasabuvir with Ribavirin [J].
Feld, Jordan J. ;
Kowdley, Kris V. ;
Coakley, Eoin ;
Sigal, Samuel ;
Nelson, David R. ;
Crawford, Darrell ;
Weiland, Ola ;
Aguilar, Humberto ;
Xiong, Junyuan ;
Pilot-Matias, Tami ;
DaSilva-Tillmann, Barbara ;
Larsen, Lois ;
Podsadecki, Thomas ;
Bernstein, Barry .
NEW ENGLAND JOURNAL OF MEDICINE, 2014, 370 (17) :1594-1603
[20]   ABT-450/r-Ombitasvir and Dasabuvir with or without Ribavirin for HCV [J].
Ferenci, Peter ;
Bernstein, David ;
Lalezari, Jacob ;
Cohen, Daniel ;
Luo, Yan ;
Cooper, Curtis ;
Tam, Edward ;
Marinho, Rui T. ;
Tsai, Naoky ;
Nyberg, Anders ;
Box, Terry D. ;
Younes, Ziad ;
Enayati, Pedram ;
Green, Sinikka ;
Baruch, Yaacov ;
Bhandari, Bal Raj ;
Caruntu, Florin Alexandru ;
Sepe, Thomas ;
Chulanov, Vladimir ;
Janczewska, Ewa ;
Rizzardini, Giuliano ;
Gervain, Judit ;
Planas, Ramon ;
Moreno, Christophe ;
Hassanein, Tarek ;
Xie, Wangang ;
King, Martin ;
Podsadecki, Thomas ;
Reddy, K. Rajender .
NEW ENGLAND JOURNAL OF MEDICINE, 2014, 370 (21) :1983-1992